SHR-1701 Combined with SHR2554 and BP102 for MCRC

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Colorectal Cancer Metastatic

Interventions

DRUG

SHR-1701

DRUG

BP102

DRUG

SHR2554

Trial Locations (1)

Department of Colorectal Surgery Fudan University Shanghai Caner Center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER